Search
Insulin glargine
go.drugbank.com/drugs/DB00047ApprovedInvestigationalAs of 2015, insulin glargine was reformulated by Sanofi as the product Toujeo in an extra-concentrated form containing 300IU/mL (compared to 100IU/mL contained in Lantus). … Insulin glargine is also available as the biosimilar, or "follow-on" product, Basaglar in the US and as Abasaglar in the EU.
Mixtures: Soliqua 100/33, SOLİQUA SOLOSTAR 100 U/ML + 33 MCG/ML SC ENJEKSİYONLUK ÇÖZELTİ İÇEREN KULLANIMA HAZIR KALEM, 5 KALEMProducts: LANTUS 100 UNITS/ML, LANTUS® 100 IU/MLAzathioprine
go.drugbank.com/drugs/DB00993ApprovedInvestigational[L11214] Azathiprine was granted FDA approval on 20 March 1968.[L11214]
Products: Azafalk 100 mg Filmtabletten, IMURAN 25 MG TABLET, 100 ADETZinc oxide
go.drugbank.com/drugs/DB09321ApprovedInvestigationalIt can be found in rubbers, plastics, ceramics, glass, cement, lubricants, paints, ointments, adhesives, sealants, pigments, foods, batteries, ferrites, fire retardants, and first-aid tapes. … It occurs naturally as the mineral zincite, but most zinc oxide is produced synthetically.
Mixtures: TANOL 100 ML LOSYON, Studio Look Base de alta cobertura para el rostro con FPS 20 Miel 200-CSynonyms: óxido de cinc, oxyde de zincAdalimumab
go.drugbank.com/drugs/DB00051ApprovedInvestigational[A39984,A39999] It was originally launched by Abbvie in the U.S. and approved in 2002 by the FDA.[A39983] This drug is frequently known as _Humira_. … It is produced by recombinant DNA technology using a mammalian cell expression system.
Products: AMGEVITA 40 MG ILO I E PEN, AMGEVITA 20 mg/0.4 ml solution for injection in pre-filled syringeExenatide
go.drugbank.com/drugs/DB01276ApprovedInvestigationalExenatide was given FDA approval on April 28, 2005[L6106]. It is available as immediate- and extended-release formulations. … It activates the GLP-1 receptor and increases insulin secretion, decreases glucagon secretion, and slows gastric emptying to improve glycemic control[L42690].
Products: BYETTA 10 µG/40 µL SC KULLANIMA HAZIR DOLU ENJEKSİYON KALEMI ICINDE COZELTI, 2.4 ML (60 DOZ), BYETTA 5 µG/20 µL SC KULLANIMA HAZIR DOLU ENJEKSİYON KALEMI ICINDE COZELTI, 1.2 ML (60 DOZ)Secukinumab
go.drugbank.com/drugs/DB09029ApprovedInvestigational[A249805] It is currently approved to treat a number of chronic inflammatory conditions, such as plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and hidradenitis suppurativa.
Products: Verxant 300 mg / 2 mL Enjeksiyonluk Çözelti İçeren Kullanıma Hazır Kalem, 1 adet, VERXANT 150 MG/1 ML ENJEKSİYONLUK ÇÖZELTİ İÇEREN KULLANIMA HAZIR KALEM, 2 ADETErgoloid mesylate
go.drugbank.com/drugs/DB01049Approved[T90] The derivatives of this fungus are identified to be about 350 different substances from which the components of the ergoloid mesylate mixture are composed of the dihydrogenated ergot alkaloid derivatives
Products: SEGOL 1 MG/ML DAMLA, ÇÖZELTİ, 50 ML, Hydergine LCRaltegravir
go.drugbank.com/drugs/DB06817ApprovedInvestigationalIt received approval by the U.S. Food and Drug Administration (FDA) on 12 October 2007, the first of a new class of HIV drugs, the integrase inhibitors, to receive such approval.
Products: Chewable Tablet 100 mg, ISENTRESS® GRÁNULOS PARA SUSPENSIÓN ORAL 100 MGDeoxycholic acid
go.drugbank.com/drugs/DB03619ApprovedInvestigationalDeoxycholic acid is a a bile acid which emulsifies and solubilizes dietary fats in the intestine, and when injected subcutaneously, it disrupts cell membranes in adipocytes and destroys fat cells in that … It is marketed under the brand name Kybella by Kythera Biopharma and is the first pharmacological agent available for submental fat reduction, allowing for a safer and less invasive alternative than surgical
Mixtures: Duchol EctProducts: BELKYRA INJECTION 10 MG/ML, Belkyra 10 mg/ml InjektionslösungTremelimumab
go.drugbank.com/drugs/DB11771ApprovedInvestigational[A253712] Tremelimumab was first approved by the FDA in October 2022 to be used in combination with [durvalumab] to treat hepatocellular carcinoma. … CTLA-4 is a cell surface receptor expressed on activated T cells to act as a negative regulator for T cells.
Products: Imjudo 300 mg/15 ml İnfüzyonluk Çözelti Hazırlamak İçin Konsantre, 1 adet, Imjudo Concentrate for Solution for Intravenous Infusion 20 mg/mL